Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 5761-5770 Newer>

BusinessWeek February 21, 2005 Adrienne Carter	Will This Merger Go Down Smoothly? On paper, the Molson-Coors deal looks like a smart move. But mergers of large, publicly held, family-dominated companies have been rare, and with good reason. They may be headed for a showdown.
BusinessWeek February 21, 2005 Robert Barker	Dolby's IPO: Are the Numbers Distorted? Closely held since its founding in 1965, audio-engineering company Dolby Laboratories aims soon to go public in a $399 million deal. But just what are its earnings?
BusinessWeek February 21, 2005 Amey Stone	How Banks Pretty Up The Profit Picture Playing with loan-loss reserves can produce deceiving earnings. Investors who assume the profits are humming and decide to buy bank stocks could be in for a shock.
BusinessWeek February 21, 2005 Gene G. Marcial	Why Sabre Could Be Going Places Scott Kuensell, managing director at Brandywine Asset Management, believes the assets of travel business Sabre Holdings are worth more than its stock price, based on recent deals.
BusinessWeek February 21, 2005 Gene G. Marcial	Iridex May Open More Investors' Eyes Iridex's stock price has fluctuated since initial results of clinical trials on its transpupillary thermotherapy product for age-related [wet] macular degeneration, a leading cause of blindness.
The Motley Fool February 10, 2005 Stephen D. Simpson	eResearch Regains Heartbeat Increased FDA and consumer worries about cardiac safety should continue to fuel the cardiac researcher's growth.
The Motley Fool February 10, 2005 Gardner & Moore	Danger! Horror! Get Out! What we avoid when investing in a small company and why we avoid it.
The Motley Fool February 10, 2005 Alyce Lomax	Comcast Hooks 'Em Up Right in time for Valentine's Day, the cable provider launches video-on-demand dating. Comcast investors might be gratified to know that it's coming up with new ways to tap additional revenue streams.
The Motley Fool February 10, 2005 Mike Cianciolo	Timberland Scales New Heights The footwear and apparel maker set records for the fourth quarter and full year.
The Motley Fool February 10, 2005 Charly Travers	Focus on the Pipeline Vertex Pharmaceuticals is losing money. But it has at least one drug that makes the future look brighter.
<Older 5761-5770 Newer> Return to current articles.